Companion Animal Vaccines Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

Companion Animal Vaccines Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

A recent market study published by Future Market Insights (FMI) on the companion animal vaccines including global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the companion animal vaccines market, growth prospects are obtained with maximum precision.

Chapter 01 – Executive Summary
The report initiates with the executive summary of the companion animal vaccines market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the companion animal vaccines market.

Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the companion animal vaccines market in this chapter, which will help them understand the basic information about the market.

Chapter 03 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the companion animal vaccines market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context
This section includes premium insights such as regulatory scenario of stages of vaccine development and approval, European regulations of veterinary biologics, mechanism of veterinary product approval, value chain analysis and list of animal vaccine manufacturers. This section helps readers understand the key factors associated with the companion animal vaccines market.

Chapter 05 – Global Companion Animal Vaccines Value Analysis 2014-2018 & Opportunity Assessment 2019-2029
This section explains the global market value analysis and forecast for the companion animal vaccines during the forecast period. This chapter includes a detailed analysis of the historical companion animal vaccines market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Product
Based on Product type, the companion animal vaccines market is segmented into attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines and recombinant vaccines. In this chapter, readers can find information about the key trends and developments in the companion animal vaccines and market attractiveness analysis based on product type.

Chapter 07 – Global Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Species
This chapter provides details about the companion animal vaccines based on species, and has been classified into canine, avian and feline. In this chapter, readers can understand the market attractiveness analysis based on species type.

Chapter 08 – Global Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel
This chapter provides details about the companion animal vaccines market based on distribution channel, and has been classified into veterinary clinics, veterinary hospitals, veterinary research and institutes and retail pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region
This chapter explains how the companion animal vaccines market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 10 – North America Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter includes a detailed analysis of growth of the North America companion animal vaccines market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides the growth scenario of the companion animal vaccines market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Europe Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the companion animal vaccines market based on its distribution channels in several countries such as Germany, the U.K., France, Spain, Italy, NORDIC Countries, BENELUX and the Rest of Europe are included in this chapter.

Chapter 13 – South Asia Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the companion animal vaccines market based on its distribution channels in several countries such as Thailand, Indonesia, Malaysia, India and the Rest of South Asia are included in this chapter.

Chapter 14 – East Asia Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the companion animal vaccines in Asia Pacific excluding Japan by focusing on Japan, South Korea and China. This section also help readers understand the key factors that are responsible for the growth of the companion animal vaccines market in the East Asia region.

Chapter 15 – Oceania Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the companion animal vaccines in Oceania. This section also help readers understand the key factors that are responsible for the growth of the companion animal vaccines market in Oceania.

Chapter 16 – MEA Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides information about how the companion animal vaccines market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period (2019-2029).

Chapter 17 – Emerging Countries Companion Animal Vaccines Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides information about how the companion animal vaccines market will grow in major countries in the emerging countries such as Mexico, China and Russia, during the forecast period (2019-2029).

Chapter 18 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the companion animal vaccines market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Merck & Co., Inc ,Elanco, Zoetis, Bayer, Merial and among others.

Chapter 19 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the companion animal vaccines report.

Chapter 20 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the companion animal vaccines.


1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
4. Market Context
4.1. Regulations- Stages of Vaccine Development & Approval
4.2. EU Veterinary Biologic Regulations
4.3. Mechanism for Veterinary Product Approval
4.4. Companion Animal Vaccines Market Value Chain
4.5. List of Companion Animal Vaccine Manufacturers
5. Global Companion Animal Vaccines Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
5.2.3. Market Value Comparison
6. Global Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
6.3.1. Attenuated Live Vaccines
6.3.2. Conjugate Vaccines
6.3.3. Inactivated Vaccines
6.3.4. Subunit Vaccines
6.3.5. Toxoid Vaccines
6.3.6. DNA Vaccines
6.3.7. Recombinant Vaccines
6.4. Market Attractiveness Analysis By Product Type
7. Global Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Species Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Species Type, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Species Type, 2019 - 2029
7.3.1. Canine
7.3.2. Avian
7.3.3. Feline
7.4. Market Attractiveness Analysis By Species Type
8. Global Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
8.3.1. Veterinary Clinics
8.3.2. Veterinary Hospitals
8.3.3. Retail Pharmacies
8.3.4. Veterinary Research Institutes
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Region Type
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By Species Type
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Species Type
10.4.4. By Distribution Channel
11. Latin America Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. Mexico
11.3.1.2. Brazil
11.3.1.3. Rest of Latin America
11.3.2. By Product Type
11.3.3. By Species Type
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Species Type
11.4.4. By Distribution Channel
12. Europe Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. BENELUX
12.3.1.8. Rest of Europe
12.3.2. By Product Type
12.3.3. By Species Type
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Species Type
12.4.4. By Distribution Channel
13. South Asia Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Thailand
13.3.1.2. India
13.3.1.3. Indonesia
13.3.1.4. Malaysia
13.3.1.5. Rest of South Asia
13.3.2. By Product Type
13.3.3. By Species Type
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Species Type
13.4.4. By Distribution Channel
14. East Asia Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. Japan
14.3.1.2. South Korea
14.3.1.3. China
14.3.2. By Product Type
14.3.3. By Species Type
14.4. By Distribution Channel Market Attractiveness Analysis
14.4.1. By Product Type
14.4.2. By Species Type
14.4.3. By Distribution Channel
15. Oceania Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Product Type
15.3.3. By Species Type
15.4. By Distribution Channel Market Attractiveness Analysis
15.4.1. By Product Type
15.4.2. By Species Type
15.4.3. By Distribution Channel
16. Middle East and Africa Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Southern Africa
16.3.1.3. Northern Africa
16.3.1.4. Rest of MEA
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Species Type
17. Emerging Countries Companion Animal Vaccines Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
17.3.1. By Country
17.3.1.1. Mexico
17.3.1.2. Russia
17.3.1.3. China
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Species Type
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Deep Dive
18.2.1. Elanco (Eli Lily and Company)
18.2.1.1. Overview
18.2.1.2. Product Portfolio
18.2.1.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.1.4. Sales Footprint
18.2.1.5. Strategy Overview
18.2.1.5.1. Marketing Strategy
18.2.1.5.2. Product Strategy
18.2.1.5.3. Species Type Strategy
18.2.2. Ceva Santé Animale
18.2.2.1. Overview
18.2.2.2. Product Portfolio
18.2.2.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.2.4. Sales Footprint
18.2.2.5. Strategy Overview
18.2.2.5.1. Marketing Strategy
18.2.2.5.2. Product Strategy
18.2.2.5.3. Species Type Strategy
18.2.3. Vetoquinol S.A
18.2.3.1. Overview
18.2.3.2. Product Portfolio
18.2.3.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.3.4. Sales Footprint
18.2.3.5. Strategy Overview
18.2.3.5.1. Marketing Strategy
18.2.3.5.2. Product Strategy
18.2.3.5.3. Species Type Strategy
18.2.4. Virbac S.A
18.2.4.1. Overview
18.2.4.2. Product Portfolio
18.2.4.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.4.4. Sales Footprint
18.2.4.5. Strategy Overview
18.2.4.5.1. Marketing Strategy
18.2.4.5.2. Product Strategy
18.2.4.5.3. Species Type Strategy
18.2.5. Heska Corp.
18.2.5.1. Overview
18.2.5.2. Product Portfolio
18.2.5.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.5.4. Sales Footprint
18.2.5.5. Strategy Overview
18.2.5.5.1. Marketing Strategy
18.2.5.5.2. Product Strategy
18.2.5.5.3. Species Type Strategy
18.2.6. Boehringer Ingelheim
18.2.6.1. Overview
18.2.6.2. Product Portfolio
18.2.6.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.6.4. Sales Footprint
18.2.6.5. Strategy Overview
18.2.6.5.1. Marketing Strategy
18.2.6.5.2. Product Strategy
18.2.6.5.3. Species Type Strategy
18.2.7. Zoetis Inc
18.2.7.1. Overview
18.2.7.2. Product Portfolio
18.2.7.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.7.4. Sales Footprint
18.2.7.5. Strategy Overview
18.2.7.5.1. Marketing Strategy
18.2.7.5.2. Product Strategy
18.2.7.5.3. Species Type Strategy
18.2.8. Bayer AG
18.2.8.1. Overview
18.2.8.2. Product Portfolio
18.2.8.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.8.4. Sales Footprint
18.2.8.5. Strategy Overview
18.2.8.5.1. Marketing Strategy
18.2.8.5.2. Product Strategy
18.2.8.5.3. Species Type Strategy
18.2.9. Merck & Co. Inc.
18.2.9.1. Overview
18.2.9.2. Product Portfolio
18.2.9.3. Profitability by Market Segments (Product/Species Type/Region)
18.2.9.4. Sales Footprint
18.2.9.5. Strategy Overview
18.2.9.5.1. Marketing Strategy
18.2.9.5.2. Product Strategy
18.2.9.5.3. Species Type Strategy
19. Assumptions and Acronyms Used
20. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook